https://wisconsinhealthpress.com/article/903309759-dr-scott-kamelle-launches-medical-scholarship-to-cultivate-innovative-problem-solvers-in-healthcare Wisconsin Health Press en PressRelease 2026-04-15T09:00:51+00:00 Dr. Scott Kamelle Launches Medical Scholarship to Cultivate Innovative Problem-Solvers in Healthcare https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24824537-dr-scott-kamelle-scholarship-f-960x1280.jpeg https://wisconsinhealthpress.com/article/905880835-tilray-brands-accelerates-next-phase-of-global-growth-and-market-leadership Wisconsin Health Press en PressRelease 2026-04-15T11:40:44+00:00 Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://wisconsinhealthpress.com/article/905879486-inside-the-science-new-white-paper-explores-the-injection-set-to-redefine-the-treatment-of-knee-osteoarthritis-unlock-access-to-non-surgical Wisconsin Health Press en PressRelease 2026-04-15T11:30:17+00:00 Inside the Science: New White Paper Explores the Injection Set to Redefine the Treatment of Knee Osteoarthritis & Unlock Access to Non-Surgical Options for Patients on the NHS https://ml-eu.globenewswire.com/media/OTcxNDdjMzktYjc5Yy00ODFkLWE3MGMtNDQyNDE5MGY5NjZiLTEzMjI2NDUtMjAyNi0wNC0xNS1lbg==/tiny/Contura-Orthopaedics-Ltd.png https://wisconsinhealthpress.com/article/905879341-medicus-pharma-to-present-new-teverelix-data-at-aace-2026-demonstrating-long-acting-hormone-suppression Wisconsin Health Press en PressRelease 2026-04-15T11:30:00+00:00 Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://wisconsinhealthpress.com/article/905879590-brainsway-highlights-growing-u-s-payer-support-for-nurse-practitioner-administered-transcranial-magnetic-stimulation-tms-therapy Wisconsin Health Press en PressRelease 2026-04-15T11:30:00+00:00 BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy https://ml.globenewswire.com/media/ea01c8f7-39be-46d2-a8e0-bc05994f170e/small/brainsway-2021-logo-jpg.jpg https://wisconsinhealthpress.com/article/905879729-arbutus-receives-u-s-fda-fast-track-designation-for-imdusiran-for-the-treatment-of-chronic-hepatitis-b Wisconsin Health Press en PressRelease 2026-04-15T11:30:00+00:00 Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg https://wisconsinhealthpress.com/article/905879994-plus-therapeutics-appoints-randy-h-goodman-phd-mha-as-vice-president-of-value-strategy-heor-to-advance-market-access-and-commercial-execution Wisconsin Health Press en PressRelease 2026-04-15T11:30:00+00:00 Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://wisconsinhealthpress.com/article/905880421-prelude-therapeutics-announces-the-appointment-of-charles-morris-m-d-as-chief-medical-officer Wisconsin Health Press en PressRelease 2026-04-15T11:30:00+00:00 Prelude Therapeutics Announces the Appointment of Charles Morris, M.D. as Chief Medical Officer https://ml.globenewswire.com/media/cab62748-b61a-42cb-b552-b0c6c91c4e83/small/ptx-logo-png.png https://wisconsinhealthpress.com/article/905880501-tg-therapeutics-announces-completion-of-enrollment-for-the-phase-3-trial-evaluating-subcutaneous-briumvi Wisconsin Health Press en PressRelease 2026-04-15T11:30:00+00:00 TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://wisconsinhealthpress.com/article/905880748-clearmind-medicine-announces-positive-data-safety-monitoring-board-recommendation-in-ongoing-cmnd-100-clinical-trial Wisconsin Health Press en PressRelease 2026-04-15T11:30:00+00:00 Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://wisconsinhealthpress.com/article/905880639-alterity-therapeutics-to-host-virtual-kol-event-to-share-new-insights-on-ath434-for-the-treatment-of-multiple-system-atrophy Wisconsin Health Press en PressRelease 2026-04-15T11:25:00+00:00 Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://wisconsinhealthpress.com/article/905879871-stereotaxis-announces-definitive-agreement-to-acquire-robocath Wisconsin Health Press en PressRelease 2026-04-15T11:00:00+00:00 Stereotaxis Announces Definitive Agreement to Acquire Robocath https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png https://wisconsinhealthpress.com/article/905879928-biocryst-to-report-first-quarter-2026-financial-results-on-may-6 Wisconsin Health Press en PressRelease 2026-04-15T11:00:00+00:00 BioCryst to Report First Quarter 2026 Financial Results on May 6 https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://wisconsinhealthpress.com/article/905880212-orvida-pharma-formerly-kamari-pharma-announces-favorable-phase-1a-safety-data-for-km-023-a-potential-first-in-disease-oral-trpv3-inhibitor-and Wisconsin Health Press en PressRelease 2026-04-15T11:00:00+00:00 Orvida Pharma (formerly Kamari Pharma) Announces Favorable Phase 1a Safety Data for KM-023, a Potential First-in-Disease Oral TRPV3 Inhibitor, and Initiation of Phase 1b Study in Patients with Olmsted Syndrome https://ml.globenewswire.com/media/cd4d7fc1-6bca-4b1d-a6b3-2314ed21fb79/small/orvida-final-46-jpg.jpg https://wisconsinhealthpress.com/article/905880223-tonix-pharmaceuticals-announces-publication-of-steady-state-pharmacokinetics-of-tonmya-after-20-days-of-daily-dosing-in-the-peer-reviewed-journal Wisconsin Health Press en PressRelease 2026-04-15T11:00:00+00:00 Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://wisconsinhealthpress.com/article/905880323-beeline-medicines-debuts-to-deliver-category-leading-precision-therapies-for-people-living-with-autoimmune-and-inflammatory-diseases Wisconsin Health Press en PressRelease 2026-04-15T11:00:00+00:00 Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases https://ml.globenewswire.com/media/a870f826-b54c-4781-bf10-d8ce2db7245a/small/beelinemedicines-logo-fullcolor-png.png https://wisconsinhealthpress.com/article/905880568-nrx-pharmaceuticals-advances-robotic-enabled-transcranial-magnetic-stimulation-combined-with-neuroplastic-therapy-for-military-and-first-responder Wisconsin Health Press en PressRelease 2026-04-15T11:00:00+00:00 NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://wisconsinhealthpress.com/article/905880425-neffy-epinephrine-nasal-spray-approved-in-canada-as-the-first-and-only-needle-free-emergency-treatment-of-allergic-reactions-anaphylaxis Wisconsin Health Press en PressRelease 2026-04-15T10:05:00+00:00 neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) https://ml.globenewswire.com/media/8feeb9d1-ed0c-491a-988b-a2b54778e825/small/ars-logo-png.png https://wisconsinhealthpress.com/article/905862956-alivecor-bringt-das-ki-gest-tzte-kardia-12l-in-europa-auf-den-markt-das-weltweit-erste-tragbare-12-kanal-ekg-mit-einzigartigem-ein-kabel-design Wisconsin Health Press en PressRelease 2026-04-15T08:01:00+00:00 AliveCor bringt das KI-gestützte Kardia 12L in Europa auf den Markt: Das weltweit erste tragbare 12-Kanal-EKG mit einzigartigem Ein-Kabel-Design https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://wisconsinhealthpress.com/article/905863061-alivecor-lanza-en-europa-el-kardia-12l-un-dispositivo-con-ia-el-primer-ecg-port-til-de-12-derivaciones-del-mundo-con-un-dise-o-nico-de-un-solo Wisconsin Health Press en PressRelease 2026-04-15T08:01:00+00:00 AliveCor lanza en Europa el Kardia 12L, un dispositivo con IA: el primer ECG portátil de 12 derivaciones del mundo con un diseño único de un solo cable https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://wisconsinhealthpress.com/article/905863140-lancement-par-alivecor-du-kardia-12l-aliment-par-l-ia-en-europe-le-premier-ecg-portable-12-d-rivations-au-monde-dot-d-une-conception-in-dite Wisconsin Health Press en PressRelease 2026-04-15T08:01:00+00:00 Lancement par AliveCor du Kardia 12L alimenté par l’IA en Europe : le premier ECG portable à 12 dérivations au monde, doté d’une conception inédite à câble unique https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://wisconsinhealthpress.com/article/905863200-alivecor-lancia-in-europa-kardia-12l-basato-su-intelligenza-artificiale-il-primo-ecg-portatile-a-12-derivazioni-al-mondo-con-un-esclusivo-design-a Wisconsin Health Press en PressRelease 2026-04-15T08:01:00+00:00 AliveCor lancia in Europa Kardia 12L basato su intelligenza artificiale: il primo ECG portatile a 12 derivazioni al mondo con un esclusivo design a cavo singolo https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://wisconsinhealthpress.com/article/905863241-alivecor-lanceert-de-ai-gestuurde-kardia-12l-in-europa-s-werelds-eerste-draagbare-12-afleidingen-ecg-met-een-uniek-ontwerp-met-n-kabel Wisconsin Health Press en PressRelease 2026-04-15T08:01:00+00:00 AliveCor lanceert de AI-gestuurde Kardia 12L in Europa: 's werelds eerste draagbare 12-afleidingen-ECG met een uniek ontwerp met één kabel https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor-rgb-horizontal-blue-2-png.png https://wisconsinhealthpress.com/article/905863456-alivecor-launches-ai-powered-kardia-12l-in-europe-the-world-s-first-handheld-12-lead-ecg-with-a-unique-single-cable-design Wisconsin Health Press en PressRelease 2026-04-15T08:01:00+00:00 AliveCor Launches AI-Powered Kardia 12L in Europe: The World’s First Handheld 12-Lead ECG with a Unique Single-Cable Design https://ml.globenewswire.com/media/d510c9dc-7eb1-45bd-ba22-aa01f14d3e40/medium/alivecor-s-kardia-12l-launches-in-europe.png https://wisconsinhealthpress.com/article/905862487-c-mo-medical-solutions-receives-ce-mark-for-its-novel-ai-powered-cough-monitoring-solution Wisconsin Health Press en PressRelease 2026-04-15T08:00:00+00:00 C-mo Medical Solutions Receives CE Mark for Its Novel AI-Powered Cough Monitoring Solution https://ml-eu.globenewswire.com/media/MjJkZjIyNmItZDRjYi00MjIyLWI0ZTgtNGU4MzI0MjEyN2FiLTEwMzc0NTQtMjAyNi0wNC0xNS1lbg==/tiny/AKAMPION.png https://wisconsinhealthpress.com/article/905843465-minervax-strengthens-executive-leadership-team-with-two-strategic-appointments-as-it-advances-its-maternal-gbs-vaccine-towards-pivotal-trial Wisconsin Health Press en PressRelease 2026-04-15T07:30:00+00:00 MinervaX Strengthens Executive Leadership Team with Two Strategic Appointments as it Advances its Maternal GBS Vaccine Towards Pivotal Trial Initiation https://ml-eu.globenewswire.com/media/e8d7e6c7-c95d-4c2e-85d8-7c656c5ee8f5/small/minervax-logo-png.png https://wisconsinhealthpress.com/article/905844405-notice-of-issuance-of-new-shares-in-connection-with-the-introduction-of-the-employee-stock-ownership-plan-matters-relating-to-stock-units-and Wisconsin Health Press en PressRelease 2026-04-15T06:34:41+00:00 Notice of Issuance of New Shares in Connection with the Introduction of the Employee Stock Ownership Plan, Matters Relating to Stock Units and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Prior RSU Award https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://wisconsinhealthpress.com/article/905844939-clinuvel-advancing-peptides-for-photomedicine-and-vitiligo-care-at-aad-2026 Wisconsin Health Press en PressRelease 2026-04-15T06:18:07+00:00 CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026 https://ml.globenewswire.com/media/a63efa41-50f1-45f2-8ee5-0d54842edcaa/medium/clinuvels-pavilion-of-photomedicine-at-aad-2026.jpg https://wisconsinhealthpress.com/article/905843826-aerska-strengthens-leadership-and-board-with-key-appointments-to-advance-systemically-delivered-rna-medicines-for-the-brain Wisconsin Health Press en PressRelease 2026-04-15T06:00:00+00:00 Aerska Strengthens Leadership and Board with Key Appointments to Advance Systemically Delivered RNA Medicines for the Brain https://ml-eu.globenewswire.com/media/a4eb676a-dff5-4c91-a519-c5b46087f6f1/small/aerska-logo-1-png.png https://wisconsinhealthpress.com/article/905843928-citryll-strengthens-intellectual-property-portfolio-with-grant-of-european-composition-of-matter-patent-for-cit-013 Wisconsin Health Press en PressRelease 2026-04-15T06:00:00+00:00 Citryll Strengthens Intellectual Property Portfolio With Grant of European Composition of Matter Patent for CIT-013 https://ml-eu.globenewswire.com/media/34e26d4c-9c72-4edc-a853-633cca05b108/small/1-citryll-logo-rgb-002-png.png https://wisconsinhealthpress.com/article/905824743-ose-immunotherapeutics-to-present-a-novel-first-in-class-fpr2-agonist-monoclonal-antibody-in-the-resolution-of-chronic-inflammation-at-the-aai-2026 Wisconsin Health Press en PressRelease 2026-04-15T05:30:00+00:00 OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://wisconsinhealthpress.com/article/905824755-ose-immunotherapeutics-pr-sentera-un-nouvel-anticorps-monoclonal-first-in-class-agoniste-de-fpr2-dans-la-r-solution-de-l-inflammation-chronique-au Wisconsin Health Press en PressRelease 2026-04-15T05:30:00+00:00 OSE Immunotherapeutics présentera un nouvel anticorps monoclonal, first-in-class, agoniste de FPR2 dans la résolution de l’inflammation chronique au Congrès 2026 de l’AAI https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ https://wisconsinhealthpress.com/article/905824846-bioversys-to-present-data-on-clinical-and-preclinical-pipeline-programs-at-escmid-global-2026 Wisconsin Health Press en PressRelease 2026-04-15T05:00:00+00:00 BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026 https://ml.globenewswire.com/media/37dee549-5eb0-418f-a16c-11d8422babfb/small/logo-bioversys-color-rgb-neu-for-prs-jpg.jpg https://wisconsinhealthpress.com/article/905824961-revolution-medicines-inc-prices-2-0-billion-in-concurrent-upsized-offerings-of-common-stock-and-convertible-senior-notes Wisconsin Health Press en PressRelease 2026-04-15T04:41:13+00:00 Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://wisconsinhealthpress.com/article/905808332-spyre-therapeutics-announces-pricing-of-upsized-403-0-million-public-offering-of-common-stock Wisconsin Health Press en PressRelease 2026-04-15T02:38:25+00:00 Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://wisconsinhealthpress.com/article/905808311-lecom-makes-pharmacy-education-more-accessible-with-three-fully-accredited-doctor-of-pharmacy-pathways Wisconsin Health Press en PressRelease 2026-04-15T02:31:27+00:00 LECOM Makes Pharmacy Education More Accessible with Three Fully Accredited Doctor of Pharmacy Pathways https://ml.globenewswire.com/Resource/Download/53969c12-c282-4b1a-a914-4ac7480a61e3/image1.jpeg https://wisconsinhealthpress.com/article/905790975-allogene-therapeutics-announces-pricing-of-public-offering-of-common-stock Wisconsin Health Press en PressRelease 2026-04-15T01:50:00+00:00 Allogene Therapeutics Announces Pricing of Public Offering of Common Stock https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://wisconsinhealthpress.com/article/905790950-american-addiction-centers-and-filmmaker-jeffrey-shulman-team-up-to-promote-powerful-new-film-on-addiction-and-recovery-with-national-theatrical-tour Wisconsin Health Press en PressRelease 2026-04-15T01:17:26+00:00 American Addiction Centers and Filmmaker Jeffrey Shulman Team Up to Promote Powerful New Film on Addiction and Recovery with National Theatrical Tour https://ml.globenewswire.com/media/1cd36806-58ee-4d6f-935f-bd2088746d5d/medium/what-it-takes-official-film-poster.JPG https://wisconsinhealthpress.com/article/905790908-arc-trt-launches-new-website-to-help-uk-men-access-personalised-testosterone-replacement-therapy Wisconsin Health Press en PressRelease 2026-04-15T01:03:33+00:00 Arc TRT Launches New Website to Help UK Men Access Personalised Testosterone Replacement Therapy https://ml.globenewswire.com/media/adfa345c-868c-4bca-bdda-15d2ab4d6315/small/arc-trt-png.png https://wisconsinhealthpress.com/article/905791055-epimab-biotherapeutics-to-present-a-novel-prodrug-t-cell-engager-protce-platform-at-the-2026-american-association-for-cancer-research-annual-meeting Wisconsin Health Press en PressRelease 2026-04-15T01:00:00+00:00 EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting https://ml.globenewswire.com/media/fa1bd13e-e49a-4b2c-a742-85957a03ad87/small/epimab-logo-for-notified-png.png https://wisconsinhealthpress.com/article/905776369-mesoblast-acquires-chimeric-antigen-receptor-car-platform-technology-for-precision-enhanced-cell-products Wisconsin Health Press en PressRelease 2026-04-15T00:10:56+00:00 Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png https://wisconsinhealthpress.com/article/905776367-telix-doses-first-patient-in-phase-3-ipax-bright-trial-of-tlx101-tx-for-recurrent-glioblastoma Wisconsin Health Press en PressRelease 2026-04-14T23:04:43+00:00 Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://wisconsinhealthpress.com/article/905763136-bruno-mars-presents-1-million-gift-to-intermountain-health-for-the-future-nevada-children-s-hospital Wisconsin Health Press en PressRelease 2026-04-14T21:40:23+00:00 Bruno Mars Presents $1 Million Gift to Intermountain Health for the Future Nevada Children’s Hospital https://ml.globenewswire.com/media/OGZmZTRlNzItNGMwOS00NDY4LWJlNzgtZGRiNjk5Mjc4ODU1LTEyNjkxMjYtMjAyNi0wNC0xNC1lbg==/tiny/Intermountain-Health.png https://wisconsinhealthpress.com/article/905763051-lymph-tonic-claims-evaluated-the-forbidden-enzyme-protocol-for-safe-weight-loss-support-by-lymphtonic Wisconsin Health Press en PressRelease 2026-04-14T21:37:48+00:00 Lymph Tonic Claims Evaluated: The Forbidden Enzyme Protocol for Safe Weight Loss Support by LymphTonic https://zingfast.com/wp-content/uploads/2026/04/Lymph-Tonic.jpg https://wisconsinhealthpress.com/article/905762991-enlitic-announces-ensight-2-2-a-breakthrough-in-imaging-data-standardization Wisconsin Health Press en PressRelease 2026-04-14T21:29:27+00:00 Enlitic Announces Ensight 2.2, a Breakthrough in Imaging Data Standardization https://ml.globenewswire.com/media/372da620-5254-4763-8d1e-53195694c648/medium/enlitic-announces-ensight-2-2-a-breakthrough-in-imaging-data.jpg https://wisconsinhealthpress.com/article/905750683-lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026 Wisconsin Health Press en PressRelease 2026-04-14T20:54:05+00:00 LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026 https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://wisconsinhealthpress.com/article/905749724-ankalax-claims-evaluated-effective-ankle-massager-brace-with-heat-therapy-vibration-compression-for-recovery Wisconsin Health Press en PressRelease 2026-04-14T20:28:01+00:00 Ankalax Claims Evaluated: Effective Ankle Massager Brace with Heat Therapy + Vibration Compression for Recovery https://zingfast.com/wp-content/uploads/2026/04/Ankalax-Ankle-Massage-Brace.jpg https://wisconsinhealthpress.com/article/905749617-update-r1-announces-phare-os-expansion-to-help-providers-navigate-growing-complexity-and-margin-pressure Wisconsin Health Press en PressRelease 2026-04-14T20:25:34+00:00 UPDATE - R1 Announces Phare OS Expansion to Help Providers Navigate Growing Complexity and Margin Pressure https://ml.globenewswire.com/media/728189a4-e254-443f-8452-315403fd70f4/small/r1-logo-black-25-947x676-jpg.jpg https://wisconsinhealthpress.com/article/905748202-heartsciences-reminds-its-shareholders-to-submit-their-vote-at-the-upcoming-april-30-2026-annual-shareholders-meeting Wisconsin Health Press en PressRelease 2026-04-14T20:15:00+00:00 HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting https://ml.globenewswire.com/media/800a6aae-74f3-42bb-9199-5e169ed9b881/small/heartsciences-png.png https://wisconsinhealthpress.com/article/905748222-aligos-therapeutics-announces-first-interim-analysis-results-from-the-phase-2-b-supreme-study-of-pevifoscorvir-sodium-in-participants-with-chronic Wisconsin Health Press en PressRelease 2026-04-14T20:05:00+00:00 Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png https://wisconsinhealthpress.com/article/905748406-structure-therapeutics-appoints-matthew-lang-j-d-as-chief-operating-officer-and-general-counsel Wisconsin Health Press en PressRelease 2026-04-14T20:05:00+00:00 Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel https://ml.globenewswire.com/media/154be1d7-62d7-4688-be20-3b2a10a2628e/small/structure-therapeutics-png.png https://wisconsinhealthpress.com/article/905748488-geron-corporation-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Wisconsin Health Press en PressRelease 2026-04-14T20:05:00+00:00 Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://wisconsinhealthpress.com/article/905748979-canadian-animal-health-institute-unleashes-cutest-pets-on-parliament-hill Wisconsin Health Press en PressRelease 2026-04-14T20:00:00+00:00 Canadian Animal Health Institute Unleashes Cutest Pets on Parliament Hill  https://ml.globenewswire.com/media/197c2953-84e0-435d-8524-c68da19d27e9/small/cahi-logo-jpg.JPG https://wisconsinhealthpress.com/article/905748980-l-institut-canadien-de-la-sant-animale-lib-re-les-animaux-de-compagnie-les-plus-mignons-sur-la-colline-du-parlement Wisconsin Health Press en PressRelease 2026-04-14T20:00:00+00:00 L’Institut canadien de la santé animale libère les animaux de compagnie les plus mignons sur la Colline du Parlement  https://ml.globenewswire.com/media/197c2953-84e0-435d-8524-c68da19d27e9/small/cahi-logo-jpg.JPG https://wisconsinhealthpress.com/article/905736235-national-roundtable-advances-women-s-health-and-chronic-pain-research-in-canada Wisconsin Health Press en PressRelease 2026-04-14T19:17:30+00:00 National Roundtable Advances Women’s Health and Chronic Pain Research in Canada https://ml.globenewswire.com/media/32c18902-bbfd-4447-afb8-37712906af67/small/centre-of-excellence-logo-png.png https://wisconsinhealthpress.com/article/905736758-la-table-ronde-nationale-fait-progresser-les-recherches-sur-la-sant-et-la-douleur-chronique-au-canada Wisconsin Health Press en PressRelease 2026-04-14T19:17:30+00:00 La table ronde nationale fait progresser les recherches sur la santé et la douleur chronique au Canada https://ml.globenewswire.com/media/32c18902-bbfd-4447-afb8-37712906af67/small/centre-of-excellence-logo-png.png https://wisconsinhealthpress.com/article/905736407-dr-eric-haeger-establishes-new-scholarship-program-to-support-future-medical-professionals-and-healthcare-innovation Wisconsin Health Press en PressRelease 2026-04-14T19:07:19+00:00 Dr. Eric Haeger Establishes New Scholarship Program to Support Future Medical Professionals and Healthcare Innovation https://ml.globenewswire.com/media/46ed0337-1c54-4d9f-b03a-6578ae568fc8/medium/dr-eric-haeger-scholarship.png https://wisconsinhealthpress.com/article/905735070-adcare-hospital-hosts-eagle-scout-led-initiative-to-support-patients-in-recovery Wisconsin Health Press en PressRelease 2026-04-14T18:45:00+00:00 AdCare Hospital Hosts Eagle Scout-Led Initiative to Support Patients in Recovery https://ml.globenewswire.com/media/d233fb10-552e-4814-b746-a0797cce4b93/small/logo-adcare-png.png https://wisconsinhealthpress.com/article/905735131-exit-156-capital-and-nightware-announce-strategic-investment-partnership Wisconsin Health Press en PressRelease 2026-04-14T18:33:00+00:00 EXIT 156 CAPITAL AND NIGHTWARE ANNOUNCE STRATEGIC INVESTMENT PARTNERSHIP https://ml.globenewswire.com/media/a6f5b4f9-8819-48df-bbb5-58f7d222ab16/small/nightware-inc-logo.png https://wisconsinhealthpress.com/article/905734763-microbot-medical-to-highlight-commercial-achievements-leading-to-the-full-market-release-fmr-of-the-liberty-endovascular-robotic-system-at-the Wisconsin Health Press en PressRelease 2026-04-14T18:30:00+00:00 Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://wisconsinhealthpress.com/article/905735393-supporting-women-s-health-can-unlock-workforce-potential-here-s-what-employers-and-allies-can-do Wisconsin Health Press en PressRelease 2026-04-14T18:24:12+00:00 Supporting Women’s Health Can Unlock Workforce Potential. Here’s What Employers and Allies Can Do https://ml.globenewswire.com/media/669af2b2-a5eb-433a-b6da-54ef95a7977b/small/whcc-logo-jpg.jpg https://wisconsinhealthpress.com/article/905735430-le-soutien-la-sant-des-femmes-maximise-le-potentiel-de-la-main-d-uvre-voici-comment-les-employeurs-et-les-alli-s-peuvent-aider Wisconsin Health Press en PressRelease 2026-04-14T18:24:12+00:00 Le soutien à la santé des femmes maximise le potentiel de la main-d’œuvre. Voici comment les employeurs et les alliés peuvent aider https://ml.globenewswire.com/media/669af2b2-a5eb-433a-b6da-54ef95a7977b/small/whcc-logo-jpg.jpg https://wisconsinhealthpress.com/article/905735110-scripps-encinitas-named-among-top-100-hospitals-in-the-u-s Wisconsin Health Press en PressRelease 2026-04-14T18:17:15+00:00 Scripps Encinitas Named Among Top 100 Hospitals in the U.S. https://ml.globenewswire.com/media/Y2Q0NWE4NGUtZjcyNi00NDM4LWJjMDQtNGRiYWE5MGJkODI4LTExMDA0OTEtMjAyNi0wNC0xNC1lbg==/tiny/Scripps-Health.png https://wisconsinhealthpress.com/article/905735261-galera-therapeutics-and-obsidian-therapeutics-announce-merger-agreement-and-350-million-concurrent-private-placement Wisconsin Health Press en PressRelease 2026-04-14T18:08:10+00:00 Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement https://ml.globenewswire.com/media/d4232a7c-0097-427f-af68-18288ab26fa6/small/galera-logo-jpg.jpg https://wisconsinhealthpress.com/article/905721688-excellent-brain-ltd-launches-new-android-version-for-neurofeedback-for-adhd-platform Wisconsin Health Press en PressRelease 2026-04-14T17:29:00+00:00 Excellent Brain Ltd. Launches New Android Version for Neurofeedback for ADHD Platform https://pressranger.s3.us-west-1.amazonaws.com/3230185/WhatsApp-Image-2026-04-05-at-12.59.39.jpeg https://wisconsinhealthpress.com/article/905721597-van-nuys-premier-rehabilitation-center-injury-docs-celebrates-10-000th-patient Wisconsin Health Press en PressRelease 2026-04-14T16:37:00+00:00 Van Nuys' Premier Rehabilitation Center, Injury Docs, Celebrates 10,000th Patient https://pressranger.s3.us-west-1.amazonaws.com/3228271/SCR-20260410-mizp.png https://wisconsinhealthpress.com/article/905707675-ose-immunotherapeutics-evolves-its-leadership-team Wisconsin Health Press en PressRelease 2026-04-14T16:00:00+00:00 OSE Immunotherapeutics Evolves its Leadership Team https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://wisconsinhealthpress.com/article/905707763-ose-immunotherapeutics-fait-voluer-son-quipe-de-direction Wisconsin Health Press en PressRelease 2026-04-14T16:00:00+00:00 OSE Immunotherapeutics fait évoluer son équipe de direction https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ https://wisconsinhealthpress.com/article/905708063-comprehensive-healthcare-launches-just-in-time-prescriber-scheduling-to-improve-access-to-behavioral-health-medication-services Wisconsin Health Press en PressRelease 2026-04-14T16:00:00+00:00 Comprehensive Healthcare Launches “Just In Time” Prescriber Scheduling to Improve Access to Behavioral Health Medication Services https://ml.globenewswire.com/media/87b3c91d-8292-48c4-aaff-e3ee4e518ee3/small/ch-logo-jpg.jpg https://wisconsinhealthpress.com/article/905708364-providence-saint-john-s-health-center-announces-largest-philanthropic-gift-in-its-history-through-transformative-stan-lucas-legacy Wisconsin Health Press en PressRelease 2026-04-14T16:00:00+00:00 Providence Saint John’s Health Center Announces Largest Philanthropic Gift in Its History Through Transformative Stan Lucas Legacy https://ml.globenewswire.com/media/5cec38c7-016b-458b-b0cf-462a36e4f605/small/saintjohnshealthcenter-2l-clr-4cp-lowerres-jpg.jpg https://wisconsinhealthpress.com/article/905708957-ascellahealth-inaugurates-strategic-advisory-council-with-founding-members-advances-pharmacy-benefits-ecosystem-through-technology-deployment-and Wisconsin Health Press en PressRelease 2026-04-14T15:30:00+00:00 AscellaHealth Inaugurates Strategic Advisory Council, With Founding Members, Advances Pharmacy Benefits Ecosystem Through Technology Deployment and Specialty Expertise https://ml.globenewswire.com/media/5278c55f-330c-41a1-8446-d8b1a07bbc55/small/ah-logo-colornotag-4x-png.png https://wisconsinhealthpress.com/article/905699380-vietnam-shocks-the-world-with-animal-to-human-organ-transplantation-technology Wisconsin Health Press en PressRelease 2026-04-14T14:56:25+00:00 Vietnam Shocks the World With Animal-To-Human Organ Transplantation Technology https://ml.globenewswire.com/media/8986a8b7-9a74-40ca-bd2f-eef76084e773/medium/vgct-s-source.jpg https://wisconsinhealthpress.com/article/905695842-major-shareholder-announcement Wisconsin Health Press en PressRelease 2026-04-14T14:44:22+00:00 Major Shareholder Announcement https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg https://wisconsinhealthpress.com/article/905697702-advanced-radiation-centers-of-new-york-launches-softray-therapy-offering-new-non-surgical-relief-of-inflammatory-tendon-and-arthritis-pain Wisconsin Health Press en PressRelease 2026-04-14T14:04:00+00:00 Advanced Radiation Centers of New York Launches SoftRay™ Therapy, Offering New Non-Surgical Relief of Inflammatory, Tendon and Arthritis Pain https://ml.globenewswire.com/media/de310bc0-7bc1-48f5-b455-ca8f8ffd0472/medium/softray-therapy-logo.png https://wisconsinhealthpress.com/article/905695461-zealand-pharma-appoints-eric-rojas-as-vice-president-and-head-of-investor-relations Wisconsin Health Press en PressRelease 2026-04-14T14:00:00+00:00 Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations https://ml-eu.globenewswire.com/media/b505bacc-6953-4eb4-ab25-e03008f97b92/medium/eric-rojas.jpg https://wisconsinhealthpress.com/article/905696037-award-winning-medical-alert-system-bay-alarm-medical-launches-caregiver-sos-youtube-series-to-support-family-caregivers Wisconsin Health Press en PressRelease 2026-04-14T14:00:00+00:00 Award-winning Medical Alert System Bay Alarm Medical Launches 'Caregiver SOS' YouTube Series to Support Family Caregivers https://pressranger.s3.us-west-1.amazonaws.com/3140430/Screenshot-2026-03-06-at-12.32.15%E2%80%AFPM.png https://wisconsinhealthpress.com/article/905696490-neion-bio-strengthens-genome-engineering-leadership-with-appointment-of-colossal-biosciences-veteran-james-kehler Wisconsin Health Press en PressRelease 2026-04-14T14:00:00+00:00 Neion Bio Strengthens Genome Engineering Leadership with Appointment of Colossal Biosciences Veteran James Kehler https://ml.globenewswire.com/media/e37518bc-d9ef-45ce-99a7-35e82f143444/medium/dr-james-kehler.jpg https://wisconsinhealthpress.com/article/905696688-reducing-administrative-burden-raises-medicaid-provider-satisfaction-by-50-new-study-finds Wisconsin Health Press en PressRelease 2026-04-14T14:00:00+00:00 Reducing Administrative Burden Raises Medicaid Provider Satisfaction by 50%, New Study Finds https://ml.globenewswire.com/media/24cdff2f-7c95-4f21-aebb-25c4628d94e7/small/gainwell-logo-suite-061720-logosuite-png-gainwell-logo-150-r.png https://wisconsinhealthpress.com/article/905697695-hibercell-to-present-preclinical-data-demonstrating-the-enhanced-antitumor-activity-of-hc-7366-in-combination-with-vegfr-tkis-in-clear-cell-renal-cell Wisconsin Health Press en PressRelease 2026-04-14T14:00:00+00:00 HiberCell to Present Preclinical Data Demonstrating the Enhanced Antitumor Activity of HC-7366 in Combination with VEGFR-TKIs in Clear Cell Renal Cell Carcinoma (ccRCC) https://ml.globenewswire.com/media/d168805a-8691-40f2-abcf-fb63a607f112/small/hybercell-jpg.jpg https://wisconsinhealthpress.com/article/905697837-grand-river-aseptic-manufacturing-announces-100-million-investment-in-sterile-manufacturing-capabilities Wisconsin Health Press en PressRelease 2026-04-14T13:55:44+00:00 Grand River Aseptic Manufacturing Announces $100 Million Investment in Sterile Manufacturing Capabilities https://ml.globenewswire.com/media/OTBkMmRlZDktNGMxYi00Mjk1LWE0YWMtZTBhYjhlOTMyMTFhLTUwMDE1MTE4Ny0yMDI2LTA0LTE0LWVu/tiny/Grand-River-Aseptic-Manufactur.png https://wisconsinhealthpress.com/article/905697955-penn-highlands-healthcare-addresses-community-needs Wisconsin Health Press en PressRelease 2026-04-14T13:44:34+00:00 Penn Highlands Healthcare Addresses Community Needs https://ml.globenewswire.com/media/ZGEyZjE1ZWMtZDA4MC00MmM1LWI0ZmQtNmVlMTM5ODUxMDgzLTEyNTYxMzgtMjAyNi0wNC0xNC1lbg==/tiny/Penn-Highlands-Healthcare.png https://wisconsinhealthpress.com/article/905686836-culture-biosciences-announces-strategic-addition-to-its-board-of-directors-to-accelerate-hardware-commercialization-and-saas-growth Wisconsin Health Press en PressRelease 2026-04-14T13:30:00+00:00 Culture Biosciences Announces Strategic Addition to Its Board of Directors to Accelerate Hardware Commercialization and SaaS Growth https://ml.globenewswire.com/media/ce8c1148-eecd-40b0-b1b7-f858ab8c3c4f/small/culture-logo-one-color-rgb-1500px-300ppi-1-1-png.png https://wisconsinhealthpress.com/article/905685691-virtuix-delivers-omni-one-to-florida-gulf-coast-university-for-use-in-physical-therapy-and-clinical-simulation Wisconsin Health Press en PressRelease 2026-04-14T13:15:00+00:00 Virtuix Delivers Omni One to Florida Gulf Coast University for Use in Physical Therapy and Clinical Simulation https://ml.globenewswire.com/media/2ba7d28b-48bc-45db-b49e-929295456dc1/medium/omni-one-at-fgu-s-marieb-college-of-health-and-human-service.jpeg https://wisconsinhealthpress.com/article/905685932-myriad-genetics-expands-access-for-mychoice-test-to-prostate-cancer-patients-in-japan Wisconsin Health Press en PressRelease 2026-04-14T13:15:00+00:00 Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://wisconsinhealthpress.com/article/905685481-nextech-reduces-healthcare-s-payment-reconciliation-burden-with-reimagined-embedded-payment-processing-platform Wisconsin Health Press en PressRelease 2026-04-14T13:00:00+00:00 Nextech Reduces Healthcare’s Payment Reconciliation Burden with Reimagined Embedded Payment Processing Platform https://ml.globenewswire.com/media/2b32c79b-9e9d-48d1-ae49-77d47537ae62/small/nextech-logo-jpg-jpg.jpg https://wisconsinhealthpress.com/article/905685781-alliance-direct-benefits-launches-alliance-complete-as-demand-grows-for-simplified-bundled-support-offerings Wisconsin Health Press en PressRelease 2026-04-14T13:00:00+00:00 Alliance Direct Benefits Launches Alliance Complete as Demand Grows for Simplified, Bundled Support Offerings https://ml.globenewswire.com/media/ZGM1MDA4YTEtODYzZi00YzgzLThkODAtMjEwNWJhZjU2NjQ2LTUwMDE2MDEwNC0yMDI2LTA0LTE0LWVu/tiny/Alliance-Direct-Benefits.png https://wisconsinhealthpress.com/article/905686904-healthedge-partners-with-ellipsis-health-to-scale-care-management-through-ai-powered-virtual-nursing Wisconsin Health Press en PressRelease 2026-04-14T13:00:00+00:00 HealthEdge® Partners with Ellipsis Health to Scale Care Management Through AI-Powered Virtual Nursing https://ml.globenewswire.com/media/18d2dfaf-8f95-4f15-99e6-ae8282b42123/small/healthedge-logo-jpg.jpg https://wisconsinhealthpress.com/article/905686993-neomorph-to-highlight-progress-in-targeted-protein-degradation-science-at-the-american-association-for-cancer-research-annual-meeting Wisconsin Health Press en PressRelease 2026-04-14T13:00:00+00:00 Neomorph to Highlight Progress in Targeted Protein Degradation Science at the American Association for Cancer Research Annual Meeting https://ml.globenewswire.com/media/d00180c1-5def-41b6-95c7-018ca5e07565/small/neomorph-logo-jpg.jpg https://wisconsinhealthpress.com/article/905687330-haystack-health-appoints-digital-health-leader-bill-snyder-as-chief-executive-officer Wisconsin Health Press en PressRelease 2026-04-14T13:00:00+00:00 Haystack Health Appoints Digital Health Leader Bill Snyder as Chief Executive Officer https://ml.globenewswire.com/media/f6629b37-d06b-4203-a6cd-f233134c4f32/small/hh-logo-png.png https://wisconsinhealthpress.com/article/905687785-merakris-therapeutics-and-ifyber-collaboration-receives-top-sawc-research-award-for-mtx-001-wound-healing-study-in-human-skin-model Wisconsin Health Press en PressRelease 2026-04-14T13:00:00+00:00 Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model https://ml.globenewswire.com/media/5b9c5fed-3332-4d4d-b8b6-6ab1b15faaed/small/mrks-brand-logo-final-fullcolor-png.png https://wisconsinhealthpress.com/article/905685907-just-salad-opens-in-east-amherst-n-y Wisconsin Health Press en PressRelease 2026-04-14T12:57:00+00:00 Just Salad Opens in East Amherst, N.Y. https://ml.globenewswire.com/media/0bfa206d-0a40-4b13-a05a-267ebef25a6a/medium/just-salad-east-amherst-new-york-storefront.jpg https://wisconsinhealthpress.com/article/905688308-entera-bio-to-host-key-opinion-leader-webinar-highlighting-the-osteoporosis-treatment-landscape-and-the-opportunity-for-eb613 Wisconsin Health Press en PressRelease 2026-04-14T12:45:00+00:00 Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613 https://ml.globenewswire.com/media/9b4ae2bf-733d-4180-b48c-d0fa3f26c81a/small/logo-png.png https://wisconsinhealthpress.com/article/905688406-actuate-therapeutics-announces-nature-medicine-publication-of-clinical-trial-results-showing-doubling-of-the-rate-of-survival-with-elraglusib-plus Wisconsin Health Press en PressRelease 2026-04-14T12:45:00+00:00 Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma https://ml.globenewswire.com/media/f65ca94c-eff8-4376-ac67-ded1b03b3bcc/small/actuatetx-logo-color300-jpg.jpg https://wisconsinhealthpress.com/article/905688494-extendicare-announces-closing-of-450-million-inaugural-offering-of-investment-grade-senior-unsecured-notes Wisconsin Health Press en PressRelease 2026-04-14T12:39:06+00:00 Extendicare Announces Closing of $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://wisconsinhealthpress.com/article/905686858-cellectar-enrolls-first-patient-in-clr-125-auger-emitting-radioconjugate-phase-1b-clinical-trial-targeting-refractory-triple-negative-breast-cancer Wisconsin Health Press en PressRelease 2026-04-14T12:35:00+00:00 Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC) https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://wisconsinhealthpress.com/article/905686003-pelthos-therapeutics-to-participate-in-piper-sandler-spring-biopharma-symposium Wisconsin Health Press en PressRelease 2026-04-14T12:30:00+00:00 Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium https://ml.globenewswire.com/media/7d71f2d0-a48f-4fe0-a49c-138de21bc0e1/small/pelthos-logo-rgb-png.png https://wisconsinhealthpress.com/article/905686896-cytodyn-to-present-at-the-aacr-annual-meeting-2026 Wisconsin Health Press en PressRelease 2026-04-14T12:30:00+00:00 CytoDyn to Present at the AACR Annual Meeting 2026 https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://wisconsinhealthpress.com/article/905687404-clinical-data-supporting-targeted-chemotherapeutic-delivery-via-renovorx-s-tamp-therapy-platform-presented-at-2026-sir-annual-scientific-meeting Wisconsin Health Press en PressRelease 2026-04-14T12:30:00+00:00 Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://wisconsinhealthpress.com/article/905688178-join-nexalin-s-exclusive-live-investor-webinar-and-q-a-session-on-april-21 Wisconsin Health Press en PressRelease 2026-04-14T12:30:00+00:00 Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21 https://ml.globenewswire.com/media/7f481b55-16b6-4c8a-8356-30d54079a605/small/nexalin-jpg.jpg https://wisconsinhealthpress.com/article/905688250-meiragtx-to-present-3-year-data-from-the-phase-1-aquax-clinical-study-of-aav-haqp1-for-the-treatment-of-grade-2-3-radiation-induced-xerostomia-on Wisconsin Health Press en PressRelease 2026-04-14T12:30:00+00:00 MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026 https://ml.globenewswire.com/media/6b45b8d0-975e-494b-8a46-b88360aa1791/small/mgx-logo-png.png https://wisconsinhealthpress.com/article/905688290-tomi-reports-strong-q1-2026-sales-of-high-margin-bit-solution-indicating-positive-growth-trends Wisconsin Health Press en PressRelease 2026-04-14T12:30:00+00:00 TOMI Reports Strong Q1 2026 Sales of High-Margin BIT Solution, Indicating Positive Growth Trends https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://wisconsinhealthpress.com/article/905687539-biomerica-launches-infoods-ibs-in-canada-through-partnerships-with-phoenix-airmid-biomedical-and-canalt-health-labs Wisconsin Health Press en PressRelease 2026-04-14T12:19:00+00:00 Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png https://wisconsinhealthpress.com/article/905673841-inspira-technologies-appoints-yoav-rozanovich-as-chief-business-officer-to-drive-immediate-revenue-growth-and-quantum-expansion Wisconsin Health Press en PressRelease 2026-04-14T12:01:00+00:00 Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png https://wisconsinhealthpress.com/article/905669423-community-routes-access-to-mental-health-care-provides-continued-funding-for-mental-health-services-at-free-charitable-clinics Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://wisconsinhealthpress.com/article/905669681-amneal-launches-first-two-respiratory-metered-dose-inhalation-products-in-the-u-s Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S. https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://wisconsinhealthpress.com/article/905669769-biovie-announces-abstract-accepted-for-presentation-at-the-2026-american-academy-of-neurology-annual-meeting Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting https://ml.globenewswire.com/media/f437d04b-c089-46eb-bca8-7ef64f68bc9b/small/biovie-logo-jpg.jpg https://wisconsinhealthpress.com/article/905669779-grace-therapeutics-announces-abstract-highlighting-strive-on-phase-3-trial-results-accepted-for-presentation-at-aan-2026 Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026 https://ml.globenewswire.com/media/c71c0a95-caed-4520-87a9-ac7fefef3f07/small/grce-logo-jpg.jpg https://wisconsinhealthpress.com/article/905670492-er-kim-signs-exclusive-distribution-agreement-with-leo-pharma-a-s-to-commercialize-loqtorzi-toripalimab-for-nasopharyngeal-and-oesophageal-cancers Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers https://ml.globenewswire.com/media/37d25207-4dc0-4c58-b0cc-d589d363d644/small/erkim-logo-jpg.jpg https://wisconsinhealthpress.com/article/905670506-hinge-bio-announces-first-subject-dosed-in-phase-1-trial-of-hb2198-a-novel-b-cell-depleting-agent-for-treating-autoimmune-disease Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Hinge Bio Announces First Subject Dosed in Phase 1 Trial of HB2198, a Novel B cell Depleting Agent, for Treating Autoimmune Disease https://ml.globenewswire.com/media/62e1a1c6-154c-4dec-bfb4-79d43b015626/small/hinge-logo-color-2021-jpg.jpg https://wisconsinhealthpress.com/article/905671256-genecentric-to-present-data-on-fragmentomics-based-expressct-liquid-biopsy-technology-at-aacr-2026 Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026 https://ml.globenewswire.com/media/90d634f2-8dea-4f53-805f-e1e0eaa71133/small/genecentric-logo-jpg.jpg https://wisconsinhealthpress.com/article/905671300-rivus-pharmaceuticals-announces-first-patients-dosed-in-amplify-phase-2-trial-for-hu6-in-mash Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Rivus Pharmaceuticals Announces First Patients Dosed in AMPLIFY Phase 2 Trial for HU6 in MASH https://ml.globenewswire.com/media/b85bbdee-9fda-4cf2-a14f-d2d608f0b949/small/rivus-pharmaceuticals-logo-png.png https://wisconsinhealthpress.com/article/905671534-carlsmed-inc-to-report-first-quarter-2026-financial-results-on-may-5-2026 Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026 https://ml.globenewswire.com/media/ee16eff2-e0d6-40ca-95c5-4dd84bb4cc5f/small/carlsmed-png.png https://wisconsinhealthpress.com/article/905671584-nanox-announces-collaboration-with-meir-medical-center-to-deploy-nanox-arc-for-orthopedic-imaging-clinical-study Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Nanox Announces Collaboration with Meir Medical Center to Deploy Nanox.ARC for Orthopedic Imaging Clinical Study https://ml.globenewswire.com/media/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2/small/nano-logo-002-jpg.jpg https://wisconsinhealthpress.com/article/905672627-corbus-pharmaceuticals-announces-last-patient-first-visit-in-canyon-1-study-of-crb-913-for-the-treatment-for-obesity Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://wisconsinhealthpress.com/article/905672678-tempest-appoints-andrew-fang-ph-d-as-head-of-business-development-to-advance-strategic-partnerships-and-global-licensing-efforts Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://wisconsinhealthpress.com/article/905672686-genvor-announces-strategic-memorandum-of-understanding-with-canlab-international-to-advance-commercial-peptide-pipeline Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline https://ml.globenewswire.com/media/8533fef9-aa8f-43c5-9088-39ab06147641/small/43464-png.png https://wisconsinhealthpress.com/article/905672832-real-world-evidence-and-industry-momentum-builds-for-imdx-s-flagship-graftassure-assay Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay https://ml.globenewswire.com/media/418fe8d1-a6a4-4025-84ba-56f14ee83865/small/imdx-logo-png.png https://wisconsinhealthpress.com/article/905673675-calidi-biotherapeutics-announces-speaker-presentation-at-iovc-conference-in-reykjav-k-iceland-on-april-28th-highlighting-the-redtail-platform-s Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Calidi Biotherapeutics Announces Speaker Presentation at IOVC Conference in Reykjavík, Iceland on April 28th Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://wisconsinhealthpress.com/article/905674131-aclarion-receives-pinnacle-award-for-ai-innovation Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Aclarion Receives Pinnacle Award for AI Innovation https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://wisconsinhealthpress.com/article/905674226-r1-announces-revenue-performance-solutions-powered-by-phare-os-to-help-providers-navigate-growing-complexity-and-margin-pressure Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 R1 Announces Revenue Performance Solutions Powered by Phare OS to Help Providers Navigate Growing Complexity and Margin Pressure https://ml.globenewswire.com/media/728189a4-e254-443f-8452-315403fd70f4/small/r1-logo-black-25-947x676-jpg.jpg https://wisconsinhealthpress.com/article/905674385-prenetics-im8-health-partners-with-vitamin-angels-to-combat-global-malnutrition-commits-to-impacting-400-000-mothers-and-children-in-year-one Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One https://ml.globenewswire.com/media/106dbe1a-a6e1-49d9-97a2-c5609258bdc7/small/pre-logo-2026-png.png https://wisconsinhealthpress.com/article/905674450-clairity-announces-update-to-nccn-guidelines-to-include-ai-mammogram-based-risk-tool-to-identify-future-breast-cancer-risk-in-women-missed-by Wisconsin Health Press en PressRelease 2026-04-14T12:00:00+00:00 Clairity Announces Update to NCCN Guidelines to Include AI Mammogram-Based Risk Tool to Identify Future Breast Cancer Risk in Women Missed by Traditional Methods https://ml.globenewswire.com/media/0087b812-cef6-4183-8b7c-093385f3bcb5/small/clairitylogo-fullcolor-vertical-rgb-png.png https://wisconsinhealthpress.com/article/905671949-avita-medical-announces-positive-interim-results-from-cohealyx-study-demonstrating-accelerated-time-to-skin-grafting Wisconsin Health Press en PressRelease 2026-04-14T11:45:00+00:00 AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://wisconsinhealthpress.com/article/905674267-clearmind-medicine-s-cmnd-100-meets-primary-endpoint-in-fda-approved-phase-i-iia-clinical-trial-for-alcohol-use-disorder Wisconsin Health Press en PressRelease 2026-04-14T11:32:00+00:00 Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://wisconsinhealthpress.com/article/905670306-sanara-medtech-inc-to-report-first-quarter-2026-financial-results-on-may-12-2026 Wisconsin Health Press en PressRelease 2026-04-14T11:30:00+00:00 Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 https://ml.globenewswire.com/media/591eb30b-d3e4-428c-9cd6-536215925b01/small/logo-jpg.jpg https://wisconsinhealthpress.com/article/905671016-profound-medical-to-participate-in-the-2026-bloom-burton-co-healthcare-investor-conference Wisconsin Health Press en PressRelease 2026-04-14T11:30:00+00:00 Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference https://ml.globenewswire.com/media/94d9e057-9de3-430c-9a19-b41ff3e06a1e/small/profound-logo-cmyk-copy-jpg.jpg https://wisconsinhealthpress.com/article/905671585-praxis-precision-medicines-announces-fda-acceptance-of-new-drug-application-for-ulixacaltamide-hcl-in-patients-with-essential-tremor Wisconsin Health Press en PressRelease 2026-04-14T11:30:00+00:00 Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://wisconsinhealthpress.com/article/905672048-anavex-life-sciences-highlights-new-scientific-findings-on-shared-biology-between-autism-and-alzheimer-s-disease Wisconsin Health Press en PressRelease 2026-04-14T11:30:00+00:00 Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png https://wisconsinhealthpress.com/article/905674084-medicenna-to-present-at-the-2026-bloom-burton-co-healthcare-investor-conference Wisconsin Health Press en PressRelease 2026-04-14T11:30:00+00:00 Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference https://ml.globenewswire.com/media/1644a38b-bed9-4a76-96fa-d57dd028e650/small/medicenna-jpg.jpg https://wisconsinhealthpress.com/article/905674299-avacta-ceo-christina-coughlin-named-as-one-of-in-vivo-s-2026-rising-leaders Wisconsin Health Press en PressRelease 2026-04-14T11:26:11+00:00 Avacta CEO Christina Coughlin Named as One of In Vivo's 2026 Rising Leaders https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg https://wisconsinhealthpress.com/article/905669756-adagene-adds-industry-veteran-peter-lebowitz-to-scientific-and-strategic-advisory-board Wisconsin Health Press en PressRelease 2026-04-14T11:00:00+00:00 Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png https://wisconsinhealthpress.com/article/905669823-trained-therapeutix-discovery-s-chief-scientific-officer-dr-mulder-honored-with-fellowship-at-the-american-institute-for-medical-and-biological Wisconsin Health Press en PressRelease 2026-04-14T11:00:00+00:00 Trained Therapeutix Discovery’s Chief Scientific Officer, Dr. Mulder, Honored with Fellowship at the American Institute for Medical and Biological Engineering (AIMBE) https://ml.globenewswire.com/media/5f6e0329-ec9c-4ab1-9659-d99b938cce16/small/trained-therapeutix-logo-png.png https://wisconsinhealthpress.com/article/905671051-shopify-to-announce-first-quarter-2026-financial-results-may-5-2026 Wisconsin Health Press en PressRelease 2026-04-14T11:00:00+00:00 Shopify to Announce First-Quarter 2026 Financial Results May 5, 2026 https://ml.globenewswire.com/media/28cdf29b-fa48-43e3-a710-ea3ab811a26c/small/shopify-logo-black-png.png https://wisconsinhealthpress.com/article/905671069-axogen-inc-to-report-first-quarter-2026-financial-results-on-april-28-2026 Wisconsin Health Press en PressRelease 2026-04-14T11:00:00+00:00 Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026 https://ml.globenewswire.com/media/3e4ffe78-2e9a-4972-915e-28c8477c84c1/small/axogen-logo-jpg.jpg https://wisconsinhealthpress.com/article/905671091-vitalhub-announces-novari-health-referral-central-intake-implementation-in-ontario Wisconsin Health Press en PressRelease 2026-04-14T11:00:00+00:00 VitalHub Announces Novari Health Referral Central Intake Implementation in Ontario https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://wisconsinhealthpress.com/article/905672083-evolveimmune-therapeutics-to-present-update-on-lead-asset-evolve104-and-new-data-for-evolve-t-cell-engager-platform-at-2026-aacr-annual-meeting Wisconsin Health Press en PressRelease 2026-04-14T11:00:00+00:00 EvolveImmune Therapeutics to Present Update on Lead Asset EVOLVE104 and New Data for EVOLVE T Cell Engager Platform at 2026 AACR Annual Meeting https://ml.globenewswire.com/media/43892ec0-88ad-4f85-b32e-7d049f9ed422/small/evolveimmune-png.png https://wisconsinhealthpress.com/article/905673210-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Wisconsin Health Press en PressRelease 2026-04-14T11:00:00+00:00 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://wisconsinhealthpress.com/article/905673892-ligand-partner-travere-therapeutics-receives-full-fda-approval-for-filspari-sparsentan-in-fsgs Wisconsin Health Press en PressRelease 2026-04-14T11:00:00+00:00 Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://wisconsinhealthpress.com/article/905674161-tiziana-life-sciences-announces-late-breaking-poster-accepted-for-presentation-at-the-7th-world-parkinson-congress Wisconsin Health Press en PressRelease 2026-04-14T11:00:00+00:00 Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress https://ml.globenewswire.com/media/991c340c-a083-4bcb-ad41-e7eea83f6f97/small/tiziana-logo-png.png https://wisconsinhealthpress.com/article/905658105-genmab-announces-net-sales-of-darzalex-daratumumab-for-first-quarter-of-2026 Wisconsin Health Press en PressRelease 2026-04-14T10:22:57+00:00 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026 https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg https://wisconsinhealthpress.com/article/905658895-ataibeckley-to-participate-in-upcoming-needham-healthcare-conferences Wisconsin Health Press en PressRelease 2026-04-14T10:00:00+00:00 AtaiBeckley to Participate in Upcoming Needham Healthcare Conferences https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png https://wisconsinhealthpress.com/article/905659602-greenwich-lifesciences-provides-update-on-financing-strategy Wisconsin Health Press en PressRelease 2026-04-14T10:00:00+00:00 Greenwich LifeSciences Provides Update on Financing Strategy https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg https://wisconsinhealthpress.com/article/905647186-nxera-pharma-s-quviviq-daridorexant-25mg-and-50mg-receives-approval-in-taiwan-for-the-treatment-of-insomnia Wisconsin Health Press en PressRelease 2026-04-14T08:42:59+00:00 Nxera Pharma’s QUVIVIQ® (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://wisconsinhealthpress.com/article/905636102-mestag-therapeutics-selected-to-present-targeted-ltbr-agonist-mst-0312-in-late-breaking-session-at-aacr-annual-meeting Wisconsin Health Press en PressRelease 2026-04-14T07:30:00+00:00 Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting https://ml-eu.globenewswire.com/media/d47c1200-a3a8-42b0-b0b9-ffb74568b42c/small/mestag-tx-logo-png.png https://wisconsinhealthpress.com/article/905636143-asgard-therapeutics-appoints-professor-dr-wolfram-brugger-as-chief-medical-officer-as-it-advances-transformative-personalized-off-the-shelf Wisconsin Health Press en PressRelease 2026-04-14T07:30:00+00:00 Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development https://ml-eu.globenewswire.com/media/5afbd1fa-9d4b-48d2-8f4f-d262d5a69053/small/asgard-tx-rgb-png.png https://wisconsinhealthpress.com/article/905614729-panntherapi-annonce-des-avanc-es-majeures-dans-son-d-veloppement-clinique-et-strat-gique Wisconsin Health Press en PressRelease 2026-04-14T06:00:00+00:00 PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique https://ml-eu.globenewswire.com/media/79af9499-0fbe-4979-88f5-7c607773acb4/small/ https://wisconsinhealthpress.com/article/905614774-renaissance-pharma-limited-an-essential-pharma-company-secures-fda-fast-track-designation-and-ind-clearance-for-daretabart-hu1418k322a-in Wisconsin Health Press en PressRelease 2026-04-14T06:00:00+00:00 Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma https://ml-eu.globenewswire.com/media/31276511-f379-4a7a-90b6-af9fc9ac2aa0/small/66795319ca361c8d044a2cc6-essential-pharma-master-logo-png.png https://wisconsinhealthpress.com/article/905614817-panntherapi-announces-significant-clinical-development-and-strategic-milestones Wisconsin Health Press en PressRelease 2026-04-14T06:00:00+00:00 PannTheraPi Announces Significant Clinical Development and Strategic Milestones https://ml-eu.globenewswire.com/media/79af9499-0fbe-4979-88f5-7c607773acb4/small/logo-png.png https://wisconsinhealthpress.com/article/905614845-kuros-biosciences-reports-51-year-over-year-increase-in-sales-in-the-first-three-months-of-2026 Wisconsin Health Press en PressRelease 2026-04-14T05:00:00+00:00 Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026 https://ml-eu.globenewswire.com/media/ad3777c9-af1f-4b09-a899-3b3d6b8e962d/small/kuros-logo-jpg.jpg https://wisconsinhealthpress.com/article/905593433-rapid-nutrition-strengthens-capital-markets-infrastructure-with-appointment-of-bowsprit-partners Wisconsin Health Press en PressRelease 2026-04-14T03:00:00+00:00 Rapid Nutrition Strengthens Capital Markets Infrastructure with Appointment of Bowsprit Partners https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://wisconsinhealthpress.com/article/905574910-elite-force-xl-male-enhancement-gummies-claims-evaluated-effective-men-s-formula-for-steel-power-support Wisconsin Health Press en PressRelease 2026-04-14T01:36:27+00:00 Elite Force XL Male Enhancement Gummies Claims Evaluated: Effective Men's Formula for Steel Power Support https://zingfast.com/wp-content/uploads/2026/04/Elite-Force-XL-Male-Enhancement-Gummies.jpg https://wisconsinhealthpress.com/article/905574767-vital-step-glp-1-claims-evaluated-trusted-doctor-prescribed-glp-1-weight-loss-medication-with-no-hidden-fees Wisconsin Health Press en PressRelease 2026-04-14T01:11:21+00:00 Vital Step GLP-1 Claims Evaluated: Trusted Doctor-Prescribed GLP-1 Weight Loss Medication with No Hidden Fees https://zingfast.com/wp-content/uploads/2026/04/Vital-Step-GLP-1.jpg https://wisconsinhealthpress.com/article/905565700-gloramd-face-lift-serum-claims-evaluated-liquid-anti-aging-wrinkle-serum-solution-for-skin-renewal Wisconsin Health Press en PressRelease 2026-04-14T00:16:02+00:00 GloraMD Face Lift Serum Claims Evaluated: Liquid Anti-Aging Wrinkle Serum Solution for Skin Renewal https://zingfast.com/wp-content/uploads/2026/04/GloraMD-Face-Lift-Serum.jpg https://wisconsinhealthpress.com/article/905557661-biomerica-reports-third-quarter-fiscal-2026-financial-results Wisconsin Health Press en PressRelease 2026-04-13T22:57:27+00:00 Biomerica Reports Third Quarter Fiscal 2026 Financial Results https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png https://wisconsinhealthpress.com/article/905557520-clean-eye-claims-evaluated-the-cleaneye-vision-care-capsules-for-retina-clear-visual-support Wisconsin Health Press en PressRelease 2026-04-13T22:46:54+00:00 Clean Eye Claims Evaluated: The CleanEye Vision Care Capsules for Retina Clear Visual Support https://zingfast.com/wp-content/uploads/2026/04/Clean-Eye.jpg https://wisconsinhealthpress.com/article/905549775-ballad-health-s-program-for-assisting-uninsured-patients-earns-national-award-for-its-community-based-approach-to-serving-rural-appalachia Wisconsin Health Press en PressRelease 2026-04-13T22:06:57+00:00 Ballad Health’s program for assisting uninsured patients earns national award for its community-based approach to serving rural Appalachia https://ml.globenewswire.com/media/MWQ0YWI3MDEtY2Q2Mi00NDk0LTk5MDAtNTEwNTEyYzRjY2Y5LTExMzUxNTItMjAyNi0wNC0xMy1lbg==/tiny/Ballad-Health.png https://wisconsinhealthpress.com/article/905549588-aim-immunotech-provides-routine-update-on-annual-filings Wisconsin Health Press en PressRelease 2026-04-13T22:00:00+00:00 AIM ImmunoTech Provides Routine Update on Annual Filings https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://wisconsinhealthpress.com/article/905542434-xortx-announces-closing-of-acquisition-of-vectus-kidney-anti-fibrotic-asset Wisconsin Health Press en PressRelease 2026-04-13T21:00:00+00:00 XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset https://ml.globenewswire.com/media/9898c4f8-b373-438a-abfa-709c4372a061/small/xortx-logo-jpg.jpg https://wisconsinhealthpress.com/article/905542368-spyre-therapeutics-announces-proposed-public-offering-of-its-common-stock Wisconsin Health Press en PressRelease 2026-04-13T20:46:48+00:00 Spyre Therapeutics Announces Proposed Public Offering of its Common Stock https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://wisconsinhealthpress.com/article/905535759-immucell-bolsters-its-innovation-strategy-with-appointments-of-dr-gilles-guillemette-and-dr-anthony-dimarco-to-the-board-and-moves-to-a-smaller Wisconsin Health Press en PressRelease 2026-04-13T20:38:05+00:00 ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors https://ml.globenewswire.com/media/680330c2-368b-4abc-9429-878b0c9fb1a2/small/immucell-jpg.jpg https://wisconsinhealthpress.com/article/905535401-bioage-labs-to-present-at-25th-annual-needham-virtual-healthcare-conference Wisconsin Health Press en PressRelease 2026-04-13T20:30:00+00:00 BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://wisconsinhealthpress.com/article/905535572-cema-cel-pivotal-trial-interim-data-highlight-strength-of-cellectis-allogeneic-car-t-platform Wisconsin Health Press en PressRelease 2026-04-13T20:30:00+00:00 Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://wisconsinhealthpress.com/article/905535574-les-donn-es-interm-diaires-de-l-essai-pivot-testant-cema-cel-mettent-en-vidence-la-solidit-de-la-plateforme-car-t-allog-nique-de-cellectis Wisconsin Health Press en PressRelease 2026-04-13T20:30:00+00:00 Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://wisconsinhealthpress.com/article/905535321-sana-biotechnology-and-mayo-clinic-announce-strategic-collaboration-focused-on-improving-care-in-type-1-diabetes-and-accelerating-development-of-sc451 Wisconsin Health Press en PressRelease 2026-04-13T20:05:00+00:00 Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451 https://ml.globenewswire.com/media/2e5b81be-ddf0-4a60-85f1-3f17c242e8c2/small/sana-biotechnology-jpg.jpg https://wisconsinhealthpress.com/article/905535567-bridgebio-oncology-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Wisconsin Health Press en PressRelease 2026-04-13T20:05:00+00:00 BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://wisconsinhealthpress.com/article/905535390-celldex-to-present-at-upcoming-investor-conference Wisconsin Health Press en PressRelease 2026-04-13T20:01:00+00:00 Celldex to Present at Upcoming Investor Conference https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png https://wisconsinhealthpress.com/article/905535566-revolution-medicines-inc-announces-proposed-offerings-of-common-stock-and-convertible-senior-notes Wisconsin Health Press en PressRelease 2026-04-13T20:01:00+00:00 Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://wisconsinhealthpress.com/article/905535570-allogene-therapeutics-announces-proposed-public-offering-of-175-million-of-common-stock Wisconsin Health Press en PressRelease 2026-04-13T20:01:00+00:00 Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://wisconsinhealthpress.com/article/905522414-celebrating-national-medical-laboratory-week Wisconsin Health Press en PressRelease 2026-04-13T19:00:00+00:00 Celebrating National Medical Laboratory Week https://ml.globenewswire.com/media/ZWNlYTAwM2UtZDAwNS00MDFjLWJiY2ItZDE4ZTM2YzQyMTM2LTEwOTc1MzMtMjAyNi0wNC0xMy1lbg==/tiny/LifeLabs.png https://wisconsinhealthpress.com/article/905516650-seer-confirms-receipt-of-unsolicited-proposal-and-director-candidate-nominations-from-radoff-jec-group Wisconsin Health Press en PressRelease 2026-04-13T17:55:00+00:00 Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://wisconsinhealthpress.com/article/905516710-vital-hemp-gummies-launch-hemp-gummies-australia-nz-or-canada-relieves-anxiety-effective-reduces-pain-relax-stress-with-vital-hemp-2026 Wisconsin Health Press en PressRelease 2026-04-13T17:39:33+00:00 Vital Hemp Gummies | Launch" Hemp Gummies Australia, NZ Or Canada Relieves Anxiety Effective Reduces Pain Relax Stress With Vital Hemp 2026 https://ml-eu.globenewswire.com/Resource/Download/3dd4c2ca-9658-477e-9266-ac54964587d8/image1.png https://wisconsinhealthpress.com/article/905511446-dermatology-devices-market-to-reach-25-6-billion-by-2030-driven-by-rising-skin-cancer-incidence-and-aesthetic-demand Wisconsin Health Press en PressRelease 2026-04-13T17:21:11+00:00 Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://wisconsinhealthpress.com/article/905511391-ask4sam-nyc-medical-malpractice-attorneys-silberstein-miklos-p-c-expands-focus-on-representing-patients-across-manhattan-brooklyn-and-queens Wisconsin Health Press en PressRelease 2026-04-13T17:05:00+00:00 ASK4SAM NYC Medical Malpractice Attorneys Silberstein & Miklos, P.C. Expands Focus on Representing Patients Across Manhattan, Brooklyn and Queens https://pressranger.s3.us-west-1.amazonaws.com/3228765/8.png https://wisconsinhealthpress.com/article/905506130-centre-for-neuro-skills-named-to-newsweek-s-america-s-greatest-midsize-workplaces-in-health-care-2026 Wisconsin Health Press en PressRelease 2026-04-13T16:17:00+00:00 Centre for Neuro Skills Named to Newsweek’s America’s Greatest Midsize Workplaces in Health Care 2026 https://ml.globenewswire.com/media/3157a281-770d-4ef2-ade7-353df4ceca6b/medium/image2.png https://wisconsinhealthpress.com/article/905506215-sienna-for-seniors-foundation-1-million-gift-advances-healthy-aging-research-at-ontario-tech-university Wisconsin Health Press en PressRelease 2026-04-13T16:13:38+00:00 Sienna for Seniors Foundation $1 Million Gift Advances Healthy Aging Research at Ontario Tech University https://ml.globenewswire.com/media/9765702b-cb47-4b36-8255-d86b22ef3df3/medium/ontario-tech-university-and-sienna-senior-living-celebrate-t.jpg https://wisconsinhealthpress.com/article/905506159-radical-catheter-technologies-announces-u-s-fda-510-k-clearance-for-its-6f-neurovascular-catheter-broadening-access-across-a-wide-range-of Wisconsin Health Press en PressRelease 2026-04-13T16:05:00+00:00 Radical™ Catheter Technologies Announces U.S. FDA 510(k) Clearance for its 6F Neurovascular Catheter -- Broadening Access Across a Wide Range of Applications https://ml.globenewswire.com/media/5177f2ec-c584-4237-9659-cc7c70377b47/small/radical-catheter-stacked-logo-jpg.jpg https://wisconsinhealthpress.com/article/905501361-american-kidney-fund-announces-2026-class-of-corporate-members-supporting-work-to-fight-kidney-disease Wisconsin Health Press en PressRelease 2026-04-13T15:37:08+00:00 American Kidney Fund Announces 2026 Class of Corporate Members Supporting Work to Fight Kidney Disease https://ml.globenewswire.com/media/MDkzZjJmMDYtN2I0OC00MTYwLWFlNTItZTBlNDJlMDBmNDk0LTExMDkwNTItMjAyNi0wNC0xMy1lbg==/tiny/American-Kidney-Fund.png https://wisconsinhealthpress.com/article/905483211-biomx-accelerates-defense-technology-buildout-with-dfsl-acquisition Wisconsin Health Press en PressRelease 2026-04-13T13:20:00+00:00 BiomX Accelerates Defense Technology Buildout with DFSL Acquisition https://ml.globenewswire.com/media/OGZiY2U5N2EtNDEzNS00MjcyLWJiZjUtODViOTA2ZTkxZjdhLTEzMjE4NzEtMjAyNi0wNC0xMy1lbg==/tiny/BiomX.png https://wisconsinhealthpress.com/article/905482689-polypid-to-present-new-phase-3-shield-ii-data-demonstrating-d-plex-sustained-local-release-at-escmid-global-2026 Wisconsin Health Press en PressRelease 2026-04-13T13:15:00+00:00 PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026 https://ml.globenewswire.com/media/6016c990-606d-49e6-a7a8-4d88bace509a/medium/figure-1.png https://wisconsinhealthpress.com/article/905483265-safespace-global-corporation-announces-operational-expansion-to-support-commercial-deployment-of-its-ai-safety-platform-and-growing-revenue-activities Wisconsin Health Press en PressRelease 2026-04-13T13:15:00+00:00 SafeSpace Global Corporation Announces Operational Expansion to Support Commercial Deployment of its AI-safety platform and Growing Revenue Activities https://ml.globenewswire.com/media/e95639ca-a47d-4c90-a44e-cf8a03b6a6d2/small/logo-jpg.jpg https://wisconsinhealthpress.com/article/905482794-switchback-medical-signs-lease-for-18-000-square-foot-facility-in-costa-rica-s-coyol-free-trade-zone Wisconsin Health Press en PressRelease 2026-04-13T13:00:00+00:00 Switchback Medical Signs Lease for 18,000 Square Foot Facility in Costa Rica’s Coyol Free Trade Zone https://ml.globenewswire.com/media/de124664-5d20-4955-8016-3dc40767830c/small/switchback-png.png https://wisconsinhealthpress.com/article/905482824-switchback-medical-firma-contrato-de-arrendamiento-para-una-instalaci-n-de-18-000-pies-cuadrados-en-la-zona-franca-coyol-de-costa-rica Wisconsin Health Press en PressRelease 2026-04-13T13:00:00+00:00 Switchback Medical firma contrato de arrendamiento para una instalación de 18,000 pies cuadrados en la Zona Franca Coyol de Costa Rica https://ml.globenewswire.com/media/de124664-5d20-4955-8016-3dc40767830c/small/switchback-png.png https://wisconsinhealthpress.com/article/905482882-neomorph-announces-closing-of-100-million-series-b-financing Wisconsin Health Press en PressRelease 2026-04-13T13:00:00+00:00 Neomorph Announces Closing of $100 Million Series B Financing https://ml.globenewswire.com/media/d00180c1-5def-41b6-95c7-018ca5e07565/small/neomorph-logo-jpg.jpg https://wisconsinhealthpress.com/article/905482931-senti-biosciences-to-present-on-logic-gated-cell-therapies-in-educational-session-at-aacr-annual-meeting-2026 Wisconsin Health Press en PressRelease 2026-04-13T13:00:00+00:00 Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/19732ef2-d354-4281-9dc5-6000f190dd83/small/sentibiologo-jpg.jpg https://wisconsinhealthpress.com/article/905478607-free-oral-cancer-screenings-in-honor-of-oral-head-and-neck-cancer-awareness-month Wisconsin Health Press en PressRelease 2026-04-13T12:45:00+00:00 Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month https://ml.globenewswire.com/media/9472c27c-8b6d-4c87-95fd-31f1f0140263/small/usosm-logo-png.png https://wisconsinhealthpress.com/article/905478665-xealth-to-facilitate-critical-discussion-among-health-system-executives-on-how-to-maximize-digital-health-value-at-becker-s-annual-meeting Wisconsin Health Press en PressRelease 2026-04-13T12:33:00+00:00 Xealth to Facilitate Critical Discussion Among Health System Executives on How to Maximize Digital Health Value at Becker’s Annual Meeting https://ml.globenewswire.com/media/33a9b40b-a04e-464b-b15f-f7180c2168ce/small/picture1-png.png https://wisconsinhealthpress.com/article/905478602-optum-united-healthcare-united-behavioral-health-expands-neurostar-tms-coverage-to-include-psychiatric-mental-health-nurse-practitioners Wisconsin Health Press en PressRelease 2026-04-13T12:32:00+00:00 Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png https://wisconsinhealthpress.com/article/905478464-alx-oncology-appoints-jeff-knight-as-chief-development-and-operating-officer Wisconsin Health Press en PressRelease 2026-04-13T12:30:00+00:00 ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://wisconsinhealthpress.com/article/905478584-oragenics-doses-first-patient-in-phase-iia-clinical-trial-of-onp-002-for-mild-traumatic-brain-injury Wisconsin Health Press en PressRelease 2026-04-13T12:30:00+00:00 Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury https://ml.globenewswire.com/media/8b2c9d06-f009-4a6e-a465-8a1fe9640993/small/logo-jpg.jpg https://wisconsinhealthpress.com/article/905478638-microbot-medical-commences-full-market-release-fmr-of-the-liberty-endovascular-robotic-system-in-the-u-s-at-the-society-of-interventional Wisconsin Health Press en PressRelease 2026-04-13T12:30:00+00:00 Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://wisconsinhealthpress.com/article/905478648-heartflow-files-patent-infringement-lawsuit-against-cleerly Wisconsin Health Press en PressRelease 2026-04-13T12:30:00+00:00 Heartflow Files Patent Infringement Lawsuit Against Cleerly https://ml.globenewswire.com/media/c6be111e-2f8e-4ac8-8fa8-310dbcbd6e15/small/25-1113-cmyk-hf-logo-positive-png.png https://wisconsinhealthpress.com/article/905478660-inspira-begins-ame-technology-implementation-process-with-one-of-the-world-s-10-largest-u-s-based-companies Wisconsin Health Press en PressRelease 2026-04-13T12:16:00+00:00 Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png https://wisconsinhealthpress.com/article/905478477-chemed-corporation-announces-a-five-year-450-million-amended-and-restated-credit-agreement Wisconsin Health Press en PressRelease 2026-04-13T12:15:00+00:00 Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement https://ml.globenewswire.com/media/1ab951c0-8d76-40e0-bc65-ebeaa1731e66/small/chemed-corp-logo-600x400-jpg.jpg